Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has today unveiled two access schemes which will enable more academically talented students from under-represented backgrounds to successfully apply to study.

© Panoramic view of Oxford Credit: Sheng Peng

The combined impact of the ambitious programmes represents a major progression for the University, with one Oxford undergraduate in four set to be from the UK’s most under-represented backgrounds by 2023.

The two new programmes – Opportunity Oxford and Foundation Oxford – aim to increase significantly the number of most promising students from groups who are currently under-represented in Oxford. Opportunity Oxford is aimed at students from more disadvantaged socio-economic backgrounds. Foundation Oxford will be open to students who have personally experienced severe disadvantage or educational disruption.

When fully up and running, these major new programmes will offer transformative paths to outstanding education for up to 250 state school students a year, representing 10% of Oxford’s UK undergraduate intake. This represents a significant step change for the University, boosting the proportion of students coming to Oxford from under-represented backgrounds from 15% of the current UK intake to 25%.

Find out more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.